PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany.\', \'Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.\', \'Department of Anesthesiology, Medicine and Physiology, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.\', \'Genome Institute of Singapore, Cardiovascular Research Institute, National University of Singapore, Centre for Translational Medicine, Singapore, Republic of Singapore.\', \'Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany. Electronic address: baer.christian@mh-hannover.de.\', \'Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany; REBIRTH Center for Translational Regenerative Medicine, Hannover Medical School, Hannover, Germany. Electronic address: thum.thomas@mh-hannover.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-2828(20)30274-110.1016/j.yjmcc.2020.08.017
?:hasPublicationType
?:journal
  • Journal of molecular and cellular cardiology
is ?:pmid of
?:pmid
?:pmid
  • 32891636
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.559
?:rankingScore_hIndex
  • 140
is ?:relation_isRelatedTo_publication of
?:title
  • MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all